Envestnet Asset Management Inc Biogen Inc. Transaction History

Envestnet Asset Management Inc

$281 Billion
Q2 2024

A detailed history of Envestnet Asset Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 198,676 shares of BIIB stock, worth $34.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

198,676

Previous 217,738 8.75%

Holding current value

$34.5 Million

Previous $47 Million 1.9%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$190.52 - $236.72 $3.63 Million - $4.51 Million	-19,062 Reduced 8.75%	198,676 $46.1 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $3.97 Million - $5.01 Million	-18,713 Reduced 7.91%	217,738 $47 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $13.9 Million - $16.8 Million	-62,600 Reduced 20.93%	236,451 $61.2 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $3.5 Million - $3.95 Million	-13,824 Reduced 4.42%	299,051 $76.9 Million
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $618 Million - $714 Million	-2,243,708 Reduced 87.76%	312,875 $89.1 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $581 Million - $662 Million	2,263,120 Added 771.18%	2,556,583 $711 Million
Q4 2022 Feb 07, 2023	SELL	$252.44 - $306.72 $3.08 Million - $3.74 Million	-12,184 Reduced 3.99%	293,463 $81.3 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $317,928 - $438,395	-1,633 Reduced 0.53%	305,647 $81.6 Million
Q2 2022 Aug 03, 2022	BUY	$187.54 - $223.02 $2.53 Million - $3 Million	13,474 Added 4.59%	307,280 $62.7 Million
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $14.6 Million - $18.5 Million	75,585 Added 34.64%	293,806 $61.9 Million
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $3.61 Million - $4.64 Million	-16,128 Reduced 6.88%	218,221 $52.4 Million
Q3 2021 Oct 07, 2021	BUY	$282.99 - $369.05 $4.75 Million - $6.2 Million	16,790 Added 7.72%	234,349 $66.3 Million
Q2 2021 Aug 04, 2021	BUY	$259.0 - $414.71 $1.29 Million - $2.07 Million	4,991 Added 2.35%	217,559 $75.3 Million
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $7.38 Million - $8.64 Million	30,362 Added 16.66%	212,568 $59.5 Million
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $2.32 Million - $3.49 Million	-9,822 Reduced 5.11%	182,206 $44.6 Million
Q3 2020 Oct 09, 2020	BUY	$264.77 - $305.71 $3.35 Million - $3.87 Million	12,657 Added 7.06%	192,028 $54.5 Million
Q2 2020 Jul 08, 2020	BUY	$258.66 - $342.55 $4 Million - $5.3 Million	15,462 Added 9.43%	179,371 $48 Million
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $1.46 Million - $1.86 Million	5,441 Added 3.43%	163,909 $51.9 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $2.81 Million - $3.88 Million	12,747 Added 8.75%	158,468 $47 Million
Q3 2019 Oct 17, 2019	BUY	$217.44 - $243.88 $1.54 Million - $1.73 Million	7,076 Added 5.1%	145,721 $33.9 Million
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $2.51 Million - $2.77 Million	-11,445 Reduced 7.63%	138,645 $32.4 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $2.3 Million - $3.59 Million	10,603 Added 7.6%	150,090 $35.5 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $27 Million - $34.2 Million	96,953 Added 227.94%	139,487 $42 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $3.93 Million - $5.15 Million	-13,405 Reduced 23.96%	42,534 $15 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $10.2 Million - $12.1 Million	39,486 Added 239.99%	55,939 $16.2 Million
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $11.3 Million - $16 Million	-43,458 Reduced 72.54%	16,453 $4.5 Million
Q4 2017 Feb 20, 2018	BUY	$307.64 - $344.58 $690,959 - $773,926	2,246 Added 3.89%	59,911 $19.1 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $1.16 Million - $1.36 Million	4,136 Added 7.73%	57,665 $18.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	53,529	53,529 $14.5 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Biogen Inc. Transaction History